X4 PHARMACEUTICALS INC (XFOR:NASDAQ)
$4.01 0.13 (3.3505%)
Analysed X4 PHARMACEUTICALS INC (XFOR:NASDAQ) News Sources
X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union
29-04-2026
yahoo.com
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
05-05-2026
yahoo.com
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
06-05-2026
yahoo.com
X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Lags Revenue Estimates
06-05-2026
yahoo.com
Here is Why X4 Pharmaceuticals (XFOR) is Among the Unrivaled Penny Stocks to Buy Now
14-05-2026
yahoo.com
X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's What You Should Know
18-05-2026
yahoo.com
Bears are Losing Control Over X4 Pharmaceuticals (XFOR), Here's Why It's a 'Buy' Now
20-05-2026
yahoo.com
How The X4 Pharmaceuticals (XFOR) Story Is Shifting With Mavorixafor And New EU Progress
21-05-2026
yahoo.com
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-06-2026
yahoo.com
What is the current price of X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The current price of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is $4.01.
X4 PHARMACEUTICALS INC (XFOR:NASDAQ) absolute price change since previous trading day?
The absolute price change of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) since the previous trading day is $0.13.
X4 PHARMACEUTICALS INC (XFOR:NASDAQ) percentage price change since previous trading day?
The percentage price change of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) since the previous trading day is 3.3505%.
What is the most recent average sentiment score for X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The most recent average sentiment score for X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The most recent sentiment for X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is .
SEC-8K** Filing Available For X4 PHARMACEUTICALS INC (XFOR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.